FindTrial
Sign In

Introduction of a microvibration culture system in in vitro maturation (IVM) treatment cycles

Introduction of a microvibration culture system in in vitro maturation (IVM) treatment cycles

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003145
Enrollment
300
Registered
2018-08-29
Start date
2013-01-01
Completion date
Unknown
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Maria Fertility Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Data was collected from patients with normal, PCO(S) who underwent HCG-primed IVM treatment cycles in the Maria Fertility Hospital (Plus). A diagnosis of PCO(S) was made based on the Rotterdam criteria. PCO(S) patients who transferred embryos derived from only GV-stage oocytes at oocytes retrieval day were included in this study.

Exclusion criteria

Exclusion criteria: PCO(S) patients who transferred embryos derived from metaphase I (MI) or MII-stage oocytes in vivo were excluded from the study.

Design outcomes

Primary

MeasureTime frame
Total number of in vitro maturation, number of normal fertilized oocytes, number of embryos cleaved, number of good quality embryos,number of surplus blastocysts vitrified, number of embryos transferred,;clinical pregnancy rate,Implantation rate, live birth rate—

Secondary

MeasureTime frame
Patients age, Body mass index, During of infertility, Endometial thickness, Antimullerian hormone,—

Countries

Korea, Republic of

Contacts

Public ContactSeong Ho Yang

Maria Fertility Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026